Elizabeth Sinclair, PhD
Director - Core Immunology Laboratory (CIL)
Division of Experimental Medicine, Department of Medicine- San Francisco General Hospital
The goal of my research is to support immunology studies that will improve the clinical management and treatment of HIV/AIDS and related co-morbidities and inform the development of an effective vaccine against HIV. Additionally, I support immunological studies of aging, stress and cardiovascular disease. CIL enables highly collaborative multidisciplinary and translational research by providing access to immunology expertise, instrumentation and a wide range of immunology assay services. As director of CIL I determine which assays best address research hypothesis; evaluate and optimize new assays; devise practical and cost effective study designs; advise on data interpretation and assist with publication. In order to support the dynamic needs of cutting-edge translational research, CIL engages in continuous optimization and validation of new assays and modification of existing assays. Area’s of high interest include: HIV Eradication; T cell activation; cellular biomarkers of immune protection and cardiovascular disease and CSF lymphocyte dynamics in HIV-infection.